1-9 of 9
Mark D. Minden
Close
Sort by
Journal Articles

Double-negative T cells utilize a TNFα–JAK1–ICAM-1 cytotoxic axis against acute myeloid leukemia

Enoch Tin, Jong Bok Lee, Ismat Khatri, Yoosu Na, Mark D. Minden, Li Zhang
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3013–3026.
https://doi.org/10.1182/bloodadvances.2023011739
Published: 2024
Includes: Supplemental data
Journal Articles

A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria

Qianghua Zhou, Davidson Zhao, Mojgan Zarif, Marta B. Davidson, Mark D. Minden, Anne Tierens, Yu Wing Tony Yeung, Cuihong Wei, Hong Chang
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1760–1771.
https://doi.org/10.1182/bloodadvances.2023011869
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN

Marta B. Davidson, James A. Kennedy, Jose-Mario Capo-Chichi, Yuliang Shi, Wei Xu, Verna Cheung, Andrea Arruda, Aniket Bankar, Guillaume Richard-Carpentier, Steven Chan, Dawn Maze, Mark D. Minden, Aaron D. Schimmer, Andre C. Schuh, Hassan Sibai, Karen Yee, Anne Tierens, Auro Viswabandya, Vikas Gupta
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1281–1294.
https://doi.org/10.1182/bloodadvances.2023011735
Published: 2024
Includes: Supplemental data
Journal Articles

A clinical laboratory–developed LSC17 stemness score assay for rapid risk assessment of patients with acute myeloid leukemia

Stanley W. K. Ng, Tracy Murphy, Ian King, Tong Zhang, Michelle Mah, Zhibin Lu, Natalie Stickle, Narmin Ibrahimova, Andrea Arruda, Amanda Mitchell, Ming Mai, Rong He, Bindu Swapna Madala, David S. Viswanatha, John E. Dick, Steven Chan, Carl Virtanen, Mark D. Minden, Timothy Mercer, Tracy Stockley, Jean C. Y. Wang
Journal: Blood Advances
Blood Adv (2022) 6 (3): 1064–1073.
https://doi.org/10.1182/bloodadvances.2021005741
Published: 2022
Includes: Supplemental data
Journal Articles

TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes

Carmelo Gurnari, Simona Pagliuca, Yihong Guan, Vera Adema, Courtney E. Hershberger, Ying Ni, Hassan Awada, Sunisa Kongkiatkamon, Misam Zawit, Diego F. Coutinho, Ilana R. Zalcberg, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Dong Hwan Kim, Mark D. Minden, Joop H. Jansen, Manja Meggendorfer, Claudia Haferlach, Babal K. Jha, Torsten Haferlach, Jaroslaw P. Maciejewski, Valeria Visconte
Journal: Blood Advances
Blood Adv (2022) 6 (1): 100–107.
https://doi.org/10.1182/bloodadvances.2021005418
Published: 2022
Includes: Supplemental data
Journal Articles

CD200 expression marks leukemia stem cells in human AML

Jenny M. Ho, Stephanie M. Dobson, Veronique Voisin, Jessica McLeod, James A. Kennedy, Amanda Mitchell, Liqing Jin, Kolja Eppert, Gary Bader, Mark D. Minden, John E. Dick, Jean C. Y. Wang
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5402–5413.
https://doi.org/10.1182/bloodadvances.2020001802
Published: 2020
Includes: Supplemental data
Journal Articles

Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML

Tracy Murphy, Jinfeng Zou, Georgina S. Daher-Reyes, Andrea Arruda, Vikas Gupta, Caroline J. McNamara, Mark D. Minden, Aaron D. Schimmer, Hassan Sibai, Karen W. L. Yee, Mariam Korulla, Tracy Stockley, Suzanne Kamel-Reid, Dawn Maze, Anne Tierens, Scott V. Bratman, Andre C. Schuh, Steven M. Chan
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2307–2311.
https://doi.org/10.1182/bloodadvances.2019000306
Published: 2019
Includes: Supplemental data
Journal Articles

The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes

Clinical Trials & Observations
Caroline J. McNamara, Tony Panzarella, James A. Kennedy, Andrea Arruda, Jaime O. Claudio, Georgina Daher-Reyes, Jenny Ho, Nancy Siddiq, Rebecca Devlin, Hubert Tsui, Jie Su, Tracy Stockley, Mahadeo Sukhai, Nisha Kanwar, Steven Chan, Dawn Maze, Aaron Schimmer, Andre Schuh, Hassan Sibai, Auro Viswabandya, Karen Yee, Mark D. Minden, Suzanne Kamel-Reid, Vikas Gupta
Journal: Blood Advances
Blood Adv (2018) 2 (20): 2658–2671.
https://doi.org/10.1182/bloodadvances.2018021469
Published: 2018
Includes: Supplemental data
Journal Articles

Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy

Clinical Trials & Observations
Jay Y. Spiegel, Caroline McNamara, James A. Kennedy, Tony Panzarella, Andrea Arruda, Tracy Stockley, Mahadeo Sukhai, Mariam Thomas, Justyna Bartoszko, Jenny Ho, Nancy Siddiq, Dawn Maze, Aaron Schimmer, Andre Schuh, Hassan Sibai, Karen Yee, Jamie Claudio, Rebecca Devlin, Mark D. Minden, Suzanne Kamel-Reid, Vikas Gupta
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1729–1738.
https://doi.org/10.1182/bloodadvances.2017009530
Published: 2017
Includes: Supplemental data